Sulfamethoxazole (31.1.8) plus trimethoprim (31.1.30) (a synthetic antibacterial drug acting as a dihydrofolate reductase inhibitor) in a 5:1 fixed ratio namedco-trimoxazole(Bactrim) is considered the first-line drug of choice for the treatment and prophylaxis of patients with urinary tract infecti...
DRUG side effectsRESEARCHNAUSEALUNG transplantationORAL drug administrationCLASSIFICATIONImportance: Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and limited treatment options. Patients with IPF have altered lung microbiota, with bacterial burden within the lungs associated with mor...